Back
Abivax SA 10K Form
Sell
17
ABVX
Abivax SA
Last Price:
7.17
Seasonality Move:
45.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ABVX News And Ratings
See the #1 stock for the next 7 days that we like better than ABVX
ABVX Financial Statistics
Sales & Book Value
| Annual Sales: | $5M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.44 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -3.54010 |
|---|---|
| Net Income (TTM): | $-159.39M |
| Gross Margin: | $-53.54M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Abivax SA Earnings Forecast
Key Abivax SA Financial Ratios
- The Gross Profit Margin over the past 10 years for ABVX is -1,107.66%.
- The Selling, General & Administrative Expenses for ABVX have been equal to 623.70% of Gross Profit Margin.
- The Research & Development expenses have been 2,232.76% of Revenue.
- The Interest Expense is -9.36% of Operating Income.
- The Net Earning history of ABVX is -3,197.14% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 3 years.
Abivax SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ABVX |
| Website: | abivax.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |